Medpace Holdings (MEDP) Receivables - Net (2015 - 2026)
Medpace Holdings' (MEDP) quarterly Receivables - Net came in at $441.8 million in Q2 2026, up 16.9% on a YoY basis from $377.9 million in Q2 2025, and up 11.97% quarter-over-quarter from $394.6 million in Q1 2026.
Analysis
Medpace Holdings (MEDP) Receivables - Net (2015 - 2026) Analysis & Trends
Medpace Holdings (MEDP) has reported Receivables - Net for 12 consecutive years, with $441.8 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Receivables - Net rose 16.9% year-over-year to $441.8 million; the trailing twelve-month figure through Jun 2026 stood at $441.8 million (up 16.9% YoY), and the FY2025 full-year result was $402.1 million, up 35.63% from the prior year.
- Receivables - Net improved to $441.8 million in Q2 2026 per MEDP's latest filing, from $394.6 million in the prior quarter.
- Across five years, Receivables - Net topped out at $441.8 million in Q2 2026 and bottomed at $224.8 million in Q1 2022.
- Historically, Receivables - Net has averaged $308.5 million across 5 years, with a median of $297.3 million in 2024.
- The sharpest annual moves came in 2022 and 2024: Receivables - Net jumped 40.48% in 2022, then declined 0.66% in 2024.
- Over 5 years, Receivables - Net stood at $253.4 million in 2022, then advanced by 17.76% to $298.4 million in 2023, then slipped by 0.66% to $296.4 million in 2024, then jumped by 35.63% to $402.1 million in 2025, then gained by 9.88% to $441.8 million in 2026.
- According to Business Quant data, Receivables - Net over the past three periods registered $441.8 million, $394.6 million, and $402.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 441.80 Mn |
| Mar 31, 2026 | 394.58 Mn |
| Dec 31, 2025 | 402.08 Mn |
| Sep 30, 2025 | 373.03 Mn |
| Jun 30, 2025 | 377.92 Mn |
| Mar 31, 2025 | 298.22 Mn |
| Dec 31, 2024 | 296.44 Mn |
| Sep 30, 2024 | 311.47 Mn |
| Jun 30, 2024 | 301.11 Mn |
| Mar 31, 2024 | 279.17 Mn |
| Dec 31, 2023 | 298.40 Mn |
| Sep 30, 2023 | 292.77 Mn |
| Jun 30, 2023 | 275.06 Mn |
| Mar 31, 2023 | 257.75 Mn |
| Dec 31, 2022 | 253.40 Mn |
| Sep 30, 2022 | 249.09 Mn |
| Jun 30, 2022 | 225.70 Mn |
| Mar 31, 2022 | 224.76 Mn |
| Dec 31, 2021 | 186.43 Mn |
| Sep 30, 2021 | 186.38 Mn |